BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32905515)

  • 1. Combination of carbon-ion beam and dual tyrosine kinase inhibitor, lapatinib, effectively destroys HER2 positive breast cancer stem-like cells.
    Sai S; Kim EH; Vares G; Suzuki M; Yu D; Horimoto Y; Hayashi M
    Am J Cancer Res; 2020; 10(8):2371-2386. PubMed ID: 32905515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro.
    Sai S; Vares G; Kim EH; Karasawa K; Wang B; Nenoi M; Horimoto Y; Hayashi M
    Mol Cancer; 2015 Sep; 14():166. PubMed ID: 26338199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo.
    Sai S; Wakai T; Vares G; Yamada S; Kamijo T; Kamada T; Shirai T
    Oncotarget; 2015 Mar; 6(8):5517-35. PubMed ID: 25849939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carbon ion beam alone or in combination with cisplatin on malignant mesothelioma cells
    Sai S; Suzuki M; Kim EH; Hayashi M; Vares G; Yamamoto N; Miyamoto T
    Oncotarget; 2018 Mar; 9(19):14849-14861. PubMed ID: 29599911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior Effect of the Combination of Carbon-Ion Beam Irradiation and 5-Fluorouracil on Colorectal Cancer Stem Cells in vitro and in vivo.
    Koom WS; Sai S; Suzuki M; Fujimori A; Yamada S; Tsujii H
    Onco Targets Ther; 2020; 13():12625-12635. PubMed ID: 33335403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells.
    Oonishi K; Cui X; Hirakawa H; Fujimori A; Kamijo T; Yamada S; Yokosuka O; Kamada T
    Radiother Oncol; 2012 Nov; 105(2):258-65. PubMed ID: 23017870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon-Ion Beam Irradiation and the miR-200c Mimic Effectively Eradicate Pancreatic Cancer Stem Cells Under in vitro and in vivo Conditions.
    Sai S; Kim EH; Koom WS; Vares G; Suzuki M; Yamada S; Hayashi M
    Onco Targets Ther; 2021; 14():4749-4760. PubMed ID: 34556996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays.
    Cui X; Oonishi K; Tsujii H; Yasuda T; Matsumoto Y; Furusawa Y; Akashi M; Kamada T; Okayasu R
    Cancer Res; 2011 May; 71(10):3676-87. PubMed ID: 21454414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib.
    Zhu X; Wu L; Qiao H; Han T; Chen S; Liu X; Jiang R; Wei Y; Feng D; Zhang Y; Ma Y; Zhang S; Zhang J
    J Cell Biochem; 2013 Dec; 114(12):2643-53. PubMed ID: 23794518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells.
    Yu T; Cho BJ; Choi EJ; Park JM; Kim DH; Kim IA
    Oncotarget; 2016 Nov; 7(48):79089-79100. PubMed ID: 27738326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
    Eustace AJ; Conlon NT; McDermott MSJ; Browne BC; O'Leary P; Holmes FA; Espina V; Liotta LA; O'Shaughnessy J; Gallagher C; O'Driscoll L; Rani S; Madden SF; O'Brien NA; Ginther C; Slamon D; Walsh N; Gallagher WM; Zagozdzon R; Watson WR; O'Donovan N; Crown J
    BMC Cancer; 2018 Oct; 18(1):965. PubMed ID: 30305055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo.
    Siddique AB; Ebrahim HY; Akl MR; Ayoub NM; Goda AA; Mohyeldin MM; Nagumalli SK; Hananeh WM; Liu YY; Meyer SA; El Sayed KA
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells: The potential of carbon ion beam radiation and new radiosensitizers (Review).
    Baek SJ; Ishii H; Tamari K; Hayashi K; Nishida N; Konno M; Kawamoto K; Koseki J; Fukusumi T; Hasegawa S; Ogawa H; Hamabe A; Miyo M; Noguchi K; Seo Y; Doki Y; Mori M; Ogawa K
    Oncol Rep; 2015 Nov; 34(5):2233-7. PubMed ID: 26330103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon-ion beam irradiation kills X-ray-resistant p53-null cancer cells by inducing mitotic catastrophe.
    Amornwichet N; Oike T; Shibata A; Ogiwara H; Tsuchiya N; Yamauchi M; Saitoh Y; Sekine R; Isono M; Yoshida Y; Ohno T; Kohno T; Nakano T
    PLoS One; 2014; 9(12):e115121. PubMed ID: 25531293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heavy ion beams induce survivin expression in human hepatoma SMMC-7721 cells more effectively than X-rays.
    Gong L; Jin X; Li Q; Liu J; An L
    Acta Biochim Biophys Sin (Shanghai); 2007 Aug; 39(8):575-82. PubMed ID: 17687492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lapatinib, a dual inhibitor of EGFR and HER2, has synergistic effects with 5-fluorouracil on esophageal carcinoma.
    Guo XF; Zhu XF; Zhong GS; Deng BG; Gao ZT; Wang H
    Oncol Rep; 2012 May; 27(5):1639-45. PubMed ID: 22293713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heavy ion irradiation increases apoptosis and STAT-3 expression, led to the cells arrested at G2/M phase in human hepatoma SMMC-7721 cells.
    Ma J; Ye L; Da M; Wang X
    Mol Cell Biochem; 2009 Aug; 328(1-2):17-23. PubMed ID: 19283452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
    Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
    Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
    Medina PJ; Goodin S
    Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell lines.
    Vannini I; Zoli W; Fabbri F; Ulivi P; Tesei A; Carloni S; Brigliadori G; Amadori D
    Anticancer Drugs; 2009 Nov; 20(10):918-25. PubMed ID: 19752719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.